臨床試験サプライ&ロジスティクス市場の規模、シェア&トレンド分析レポート:サービス別(物流&配布、保管&保持)、フェーズ別、エンドユース別、治療領域別、地域別、セグメント予測、2022年~2030年Clinical Trials Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By End Use, By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030 臨床試験サプライ&ロジスティクス市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、世界の臨床試験サプライ&ロジスティクス市場は、2030年までに62億3000万米ドルに達すると予測され... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー臨床試験サプライ&ロジスティクス市場の成長とトレンドグランドビューリサーチ社の最新レポートによると、世界の臨床試験サプライ&ロジスティクス市場は、2030年までに62億3000万米ドルに達すると予測されています。この市場は、2022年から2030年にかけて7.4%の有利なCAGRで拡大すると予測されています。これは、臨床試験サプライ&ロジスティクス市場における先進技術やイノベーションの台頭、厳しい規制の実施、COVID-19パンデミックなどの疾患の流行による臨床試験需要の増加によるものです。 当初、COVID-19のパンデミックは、サプライチェーンの混乱や、ウイルスの拡散を防ぐための政府による民間航空会社の削減により、市場にマイナスの影響を及ぼしました。しかし、パンデミックの後半には、COVID-19ワクチンの需要が高まり、市場は回復に向かいました。例えば、WHOによると、2022年8月2日現在、臨床開発段階にあるワクチンは169種類、前臨床段階にあるワクチンは198種類となっています。 また、温度管理だけでなくコールドチェーン管理も含めた効率的な物流やサプライチェーン管理の需要が高まっていることから、臨床試験のアウトソーシングが増加しています。コールドチェーンロジスティクスに対する世界のバイオ医薬品の支出は大幅に増加しており、この傾向は今後も続くと予想され、臨床試験供給・ロジスティクス市場を牽引することが期待されます。例えば、2022年2月、キャタレントは、中国の上海に外高橋自由貿易区(FTZ)施設を建設し、温度管理下での臨床供給品の流通と保管のための能力を強化するとともに、二次的である包装能力を追加する計画を発表しています。 臨床試験サプライ&ロジスティクス市場のレポートハイライト - サービス分野では、2021年にロジスティクス&ディストリビューションが市場を支配しました。これは、COVID- 19のパンデミックによる臨床試験の増加によるものです。 - フェーズ別では、フェーズIIIセグメントが2021年に43.3%の市場シェアを獲得し、市場を支配している - 治療領域別では、予測期間中に心血管疾患が最も速いCAGRを占めた。これは、新規かつ革新的な製品を市場に投入するための市場関係者による投資の増加によるものです。 - アジア太平洋地域は、予測期間中に最も速い成長率を記録すると予想されます。これは、募集コストが低いこと、大規模で多様な患者プールへのアクセスが可能であること、臨床試験に望ましいとされる有利な政策があることなどによります。 目次Table of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates & Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 GVR’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Region Wise Market Calculation 1.6.1 Region Wise Market: Base Estimates 1.6.2 Global Market: CAGR Calculation 1.7 List of Secondary Sources 1.8 Objectives 1.8.1 Objective - 1: Understanding market dynamics 1.8.2 Objective - 2: Understanding market estimates and forecasts 1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization 1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size. Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Clinical Trial Supply & Logistics Market: Variables, Trends, & Scope 3.1 Market Segmentation and Scope 3.2 Market Dynamics 3.2.1 Market Driver Analysis 3.2.1.1 Technological advancements in supply chain 3.2.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms 3.2.2 Market Restraint Analysis 3.2.2.2 Stringent regulation pertaining to Logistics 3.3 Penetration & Growth Prospect Mapping 3.4 COVID-19 Impact on the Clinical Trials Supply & Logistics Market 3.5 Major Deals and Strategic Alliances Analysis 3.6 Clinical Trial Supply & Logistics: Market Analysis Tools 3.6.1 Industry Analysis - Porter’s 3.6.3 PESTEL Analysis Chapter 4 Clinical Trial Supply & Logistics Market: Service Segment Analysis 4.1 Clinical Trial Supply & Logistics Market: Service Market Share Analysis, 2021 & 2030 4.2 Logistics & Distribution 4.2.1 Logistics & Distribution Market, 2018 - 2030 (USD Million) 4.3 Storage & Retention 4.3.1 Storage & Retention Market, 2018 - 2030 (USD Million) 4.4 Packaging, labeling, and blinding 4.4.1 Packaging, labeling, and blinding Market, 2018 - 2030 (USD Million) 4.5 Manufacturing 4.5.1 Manufacturing Market, 2018 - 2030 (USD Million) 4.6 Comparator sourcing 4.6.1 Comparator sourcing Market, 2018 - 2030 (USD Million) 4.7 Other services (solutions, ancillary supply) 4.7.1 Other services (solutions, ancillary supply) Market, 2018 - 2030 (USD Million) Chapter 5 Clinical Trial Supply & Logistics Market: Phase Segment Analysis 5.1 Clinical Trial Supply & Logistics: Phase Market Share Analysis, 2021 & 2030 5.2 Phase I 5.2.1 Phase I Market, 2018 - 2030 (USD Million) 5.3 Phase II 5.3.1 Phase II Market, 2018 - 2030 (USD Million) 5.4 Phase III 5.4.1 Phase III Market, 2018 - 2030 (USD Million) 5.5 Phase IV 5.5.1 Phase IV Market, 2018 - 2030 (USD Million) Chapter 6 Clinical Trial Supply & Logistics Market: End-user Segment Analysis 6.1 Clinical Trial Supply & Logistics: End-user Market Share Analysis, 2021 & 2030 6.2 Pharmaceuticals 6.2.1 Pharmaceuticals Market, 2018 - 2030 (USD Million) 6.3 Biologicals 6.3.1 Biologicals Market, 2018 - 2030 (USD Million) 6.4 Medical Devices 6.4.1 Medical Devices Market, 2018 - 2030 (USD Million) Chapter 7 Clinical Trial Supply & Logistics Market: Therapeutic Area Segment Analysis 7.1 Clinical Trial Supply & Logistics: Therapeutic area Market Share Analysis, 2021 & 2030 7.2 Oncology 7.2.1 Oncology Market, 2018 - 2030 (USD Million) 7.3 Cardiovascular Disease 7.3.1 Cardiovascular Disease Market, 2018 - 2030 (USD Million) 7.4 Respiratory Disease 7.4.1 Respiratory Disease Market, 2018 - 2030 (USD Million) 7.5 CNS & Mental Disorders 7.5.1 CNS & Mental Disorders Market, 2018 - 2030 (USD Million) 7.6 Others 7.6.1 Others Market, 2018 - 2030 (USD Million) Chapter 8 Clinical Trial Supply & Logistics Market: Regional Analysis 8.1 Clinical Trial Supply & Logistics Market: Regional Market Share Analysis, 2021 & 2030 8.2 North America 8.2.1 North America Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.2.3 Canada 8.2.3.1 Canada Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3 Europe 8.3.1 Europe Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.2 U.K. 8.3.2.1 U.K. Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.3 Germany 8.3.3.1 Germany Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.4 France 8.3.4.1 France Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.5 Italy 8.3.5.1 Italy Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.6 Spain 8.3.6.1 Spain Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.2 Japan 8.4.2.1 Japan Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.3 China 8.4.3.1 China Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.4 India 8.4.4.1 India Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.5 Australia 8.4.5.1 Australia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.6 South Korea 8.4.6.1 South Korea Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5 Latin America 8.5.1 Latin America Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.2 Brazil 8.5.2.1 Brazil Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.3 Mexico 8.5.3.1 Mexico Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.4 Argentina 8.5.4.1 Argentina Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.5 Colombia 8.5.5.1 Colombia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.6 Chile 8.5.6.1 Chile Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6 MEA 8.6.1 MEA Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.3 Saudi Arabia 8.6.3.1 Saudi Arabia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.4 UAE 8.6.4.1 UAE Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.5 Israel 8.6.5.1 Israel Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.6 Iran 8.6.6.1 Iran Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) Chapter 9 Company Profiles 9.1 Catalent Inc 9.1.1 Company Overview 9.1.2 Service Benchmarking 9.1.3 Financial Performance 9.1.4 Strategic Initiatives 9.2 Thermo Fisher Scientific (Patheon) 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Service Benchmarking 9.2.4 Strategic Initiatives 9.3 Parexel 9.3.1 Company Overview 9.3.2 Service Benchmarking 9.3.3 Strategic Initiatives 9.4 Almac Group 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Service Benchmarking 9.5 Marken 9.5.1 Company Overview 9.5.2 Financial Performance 9.5.3 Service Benchmarking 9.6 Piramal Pharma Solutions 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Service Benchmarking 9.7 UDG Healthcare 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Service Benchmarking 9.7.4 Strategic Initiatives 9.8 DHL 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Service Benchmarking 9.9 FedEx 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Service Benchmarking 9.9.4 Strategic Initiatives 9.9.5 Strategic Initiatives 9.10 Packaging Coordinators Inc. 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Service Benchmarking 9.10.4 Strategic Initiatives
SummaryClinical Trials Supply & Logistics Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates & Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 GVR’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Region Wise Market Calculation 1.6.1 Region Wise Market: Base Estimates 1.6.2 Global Market: CAGR Calculation 1.7 List of Secondary Sources 1.8 Objectives 1.8.1 Objective - 1: Understanding market dynamics 1.8.2 Objective - 2: Understanding market estimates and forecasts 1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization 1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size. Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Clinical Trial Supply & Logistics Market: Variables, Trends, & Scope 3.1 Market Segmentation and Scope 3.2 Market Dynamics 3.2.1 Market Driver Analysis 3.2.1.1 Technological advancements in supply chain 3.2.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms 3.2.2 Market Restraint Analysis 3.2.2.2 Stringent regulation pertaining to Logistics 3.3 Penetration & Growth Prospect Mapping 3.4 COVID-19 Impact on the Clinical Trials Supply & Logistics Market 3.5 Major Deals and Strategic Alliances Analysis 3.6 Clinical Trial Supply & Logistics: Market Analysis Tools 3.6.1 Industry Analysis - Porter’s 3.6.3 PESTEL Analysis Chapter 4 Clinical Trial Supply & Logistics Market: Service Segment Analysis 4.1 Clinical Trial Supply & Logistics Market: Service Market Share Analysis, 2021 & 2030 4.2 Logistics & Distribution 4.2.1 Logistics & Distribution Market, 2018 - 2030 (USD Million) 4.3 Storage & Retention 4.3.1 Storage & Retention Market, 2018 - 2030 (USD Million) 4.4 Packaging, labeling, and blinding 4.4.1 Packaging, labeling, and blinding Market, 2018 - 2030 (USD Million) 4.5 Manufacturing 4.5.1 Manufacturing Market, 2018 - 2030 (USD Million) 4.6 Comparator sourcing 4.6.1 Comparator sourcing Market, 2018 - 2030 (USD Million) 4.7 Other services (solutions, ancillary supply) 4.7.1 Other services (solutions, ancillary supply) Market, 2018 - 2030 (USD Million) Chapter 5 Clinical Trial Supply & Logistics Market: Phase Segment Analysis 5.1 Clinical Trial Supply & Logistics: Phase Market Share Analysis, 2021 & 2030 5.2 Phase I 5.2.1 Phase I Market, 2018 - 2030 (USD Million) 5.3 Phase II 5.3.1 Phase II Market, 2018 - 2030 (USD Million) 5.4 Phase III 5.4.1 Phase III Market, 2018 - 2030 (USD Million) 5.5 Phase IV 5.5.1 Phase IV Market, 2018 - 2030 (USD Million) Chapter 6 Clinical Trial Supply & Logistics Market: End-user Segment Analysis 6.1 Clinical Trial Supply & Logistics: End-user Market Share Analysis, 2021 & 2030 6.2 Pharmaceuticals 6.2.1 Pharmaceuticals Market, 2018 - 2030 (USD Million) 6.3 Biologicals 6.3.1 Biologicals Market, 2018 - 2030 (USD Million) 6.4 Medical Devices 6.4.1 Medical Devices Market, 2018 - 2030 (USD Million) Chapter 7 Clinical Trial Supply & Logistics Market: Therapeutic Area Segment Analysis 7.1 Clinical Trial Supply & Logistics: Therapeutic area Market Share Analysis, 2021 & 2030 7.2 Oncology 7.2.1 Oncology Market, 2018 - 2030 (USD Million) 7.3 Cardiovascular Disease 7.3.1 Cardiovascular Disease Market, 2018 - 2030 (USD Million) 7.4 Respiratory Disease 7.4.1 Respiratory Disease Market, 2018 - 2030 (USD Million) 7.5 CNS & Mental Disorders 7.5.1 CNS & Mental Disorders Market, 2018 - 2030 (USD Million) 7.6 Others 7.6.1 Others Market, 2018 - 2030 (USD Million) Chapter 8 Clinical Trial Supply & Logistics Market: Regional Analysis 8.1 Clinical Trial Supply & Logistics Market: Regional Market Share Analysis, 2021 & 2030 8.2 North America 8.2.1 North America Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.2.3 Canada 8.2.3.1 Canada Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3 Europe 8.3.1 Europe Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.2 U.K. 8.3.2.1 U.K. Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.3 Germany 8.3.3.1 Germany Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.4 France 8.3.4.1 France Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.5 Italy 8.3.5.1 Italy Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.3.6 Spain 8.3.6.1 Spain Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.2 Japan 8.4.2.1 Japan Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.3 China 8.4.3.1 China Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.4 India 8.4.4.1 India Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.5 Australia 8.4.5.1 Australia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.4.6 South Korea 8.4.6.1 South Korea Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5 Latin America 8.5.1 Latin America Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.2 Brazil 8.5.2.1 Brazil Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.3 Mexico 8.5.3.1 Mexico Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.4 Argentina 8.5.4.1 Argentina Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.5 Colombia 8.5.5.1 Colombia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.5.6 Chile 8.5.6.1 Chile Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6 MEA 8.6.1 MEA Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.3 Saudi Arabia 8.6.3.1 Saudi Arabia Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.4 UAE 8.6.4.1 UAE Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.5 Israel 8.6.5.1 Israel Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) 8.6.6 Iran 8.6.6.1 Iran Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million) Chapter 9 Company Profiles 9.1 Catalent Inc 9.1.1 Company Overview 9.1.2 Service Benchmarking 9.1.3 Financial Performance 9.1.4 Strategic Initiatives 9.2 Thermo Fisher Scientific (Patheon) 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Service Benchmarking 9.2.4 Strategic Initiatives 9.3 Parexel 9.3.1 Company Overview 9.3.2 Service Benchmarking 9.3.3 Strategic Initiatives 9.4 Almac Group 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Service Benchmarking 9.5 Marken 9.5.1 Company Overview 9.5.2 Financial Performance 9.5.3 Service Benchmarking 9.6 Piramal Pharma Solutions 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Service Benchmarking 9.7 UDG Healthcare 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Service Benchmarking 9.7.4 Strategic Initiatives 9.8 DHL 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Service Benchmarking 9.9 FedEx 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Service Benchmarking 9.9.4 Strategic Initiatives 9.9.5 Strategic Initiatives 9.10 Packaging Coordinators Inc. 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Service Benchmarking 9.10.4 Strategic Initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療IT)の最新刊レポート
Grand View Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(clinical trials)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |